Extending EMA competences to medical devices in the EU - is there any alternative?
This article was originally published in RAJ Devices
The European Commission is not talking about introducing a system for pre-market approval for medical devices by the European Medicines Agency, but rather about giving a centralised body – which could be the EMA – a co-ordinating role, for instance in areas concerning notified bodies.
You may also be interested in...
The European Parliament is about to sign off corrigenda to the Medical Devices and IVD Regulations. The headline news is a longer transition period for a huge swathe of class I products, but there are other changes too.
The two-year delay to Eudamed was a Commission decision. Now the competent authorities are fighting back and the issue is to be discussed at the level of the Council of the European Union on December 9 to avoid “heavily burdensome administrative transitional solutions.”
With six months left to the full implementation of the EU’s Medical Devices Regulation, there are a couple of big shifts taking place in the way it is being applied. Following news of the Eudamed database two-year delay, confirmation looks imminent that many more products will avoid having to comply with the MDR by next May. But will this plan sufficiently alleviate implementation pressures?